Crescent Energy enters the second half of 2026 with an upgraded production outlook, structurally lower per-unit costs, and a Permian synergy program running well ahead of schedule. Second-quarter production of 335 MBoe/d, with 140 MBo/d of oil, marked a step-change versus the prior-year quarter on the back of integrated SilverBow assets and the closing of the Vital Energy transaction. Realized oil price ex-derivatives of $96.61/Bbl combined with disciplined hedging to support a record quarter. Adjusted EBITDAX reached $798M and Levered Free Cash Flow hit $418M, both records. The combination of a fixed quarterly dividend, $336M of buyback authorization remaining, and a balance sheet shorn of its nearest maturity positions the equity for a re-rating tied to free-cash conversion. The leverage ratio of approximately 2.4x sits well below the mid-cap E&P average. The combination of these operating and balance-sheet signals underwrites the constructive forward view.
The strategic question is no longer whether Crescent can integrate large-scale E&P acquisitions at attractive returns, but whether the resulting scale and synergy capture can sustain single-digit free-cash-flow yields through the cycle. Operating cost of $13.38/Boe runs below the original guidance. Adjusted operating cost of $10.95/Boe runs roughly 9% below the prior mid-point, evidencing that the cost base is bending down. With $1.49 of diluted earnings per share in the quarter and $263M of Adjusted Net Income, the income statement has shifted decisively from a sponsor-backed roll-up narrative to an operational free-cash-flow platform. The Permian synergy program, with $190M captured and a higher target, provides a multi-year tailwind. It does not require incremental capital and compounds the per-Boe margin advantage. The fixed dividend and the buyback authorization together provide a clear floor for shareholder return, while the balance sheet deleveraging trajectory underwrites the durability of those returns.
The principal tension is the gap between share price reaction and the underlying cash-generation profile. Crescent trades around $13.96 against a fifty-two week high of $14.54. The enterprise value sits near $9.5B with trailing EBITDA around $2.0B. Net debt of $4.9B implies a leverage ratio of approximately 2.4x EBITDA, a level that supports continued buyback execution and a measured pace of inorganic bolt-ons. The equity offers an asymmetric setup if 2026 production lands at the upper end of guidance and the Permian synergy target ratchets higher.